Literature DB >> 8772705

Noninvasive quantification of regional myocardial metabolic rate of oxygen by 15O2 inhalation and positron emission tomography. Experimental validation.

Y Yamamoto1, R de Silva, C G Rhodes, H Iida, A A Lammertsma, T Jones, A Maseri.   

Abstract

BACKGROUND: The purpose of this study was to validate a novel method for noninvasive quantification of regional myocardial oxygen consumption (MMRO2, mL.min-1 x 100 g-1) and oxygen extraction fraction (OEF) by use of positron emission tomography (PET) and inhalation of 15O-labeled molecular oxygen gas (15O2). METHODS AND
RESULTS: Twenty-four measurements were performed in eight closed-chest anesthetized greyhounds at baseline and during infusions of adenosine (100 to 200 micrograms.kg-1.min-1), isoproterenol (1 to 10 microgram/min), and propranolol (5 mg botus +0.2 to 1 mg/min) with morphine (5 mg slow infusion +0.2 to 0.5 mg/ min) to obtain a wide range of oxidative metabolism. The PET imaging protocol consisted of 15O2 emission (OEF and MMRO2), transmission, [15O]CO emission (blood pool), and [15O]CO2 emission (myocardial blood flow: MBF(pets) mL.min-1.g-1) scans. OEF was calculated from the PET data (OEFpet) by three different analytical techniques: steady-state, 5-minute, and 8-minute autoradiographic analyses. Reference measurements of MBF (MBFref) and OEF (OEFref) were obtained during 15O2 inhalation with radiolabeled microspheres and paired arterial and coronary sinus blood sampling, respectively. MMRO2 was calculated from the PET (MMRO2pet) and the reference (MMRO2ref) data as follows: MMRO2 = OEF x MBF x (O2 content of arterial blood). OEF measured by the steady-state PET method was well correlated with the reference data over the range 0.16 to 0.73 (OEFpet = 1.03 OEFref -0.01, r = .97), as was MMRO2 over the range 2.4 to 27.5 mL.min-1 x 100 g-1 (MMRO2pet = 0.98 MMRO2ref +0.91, r = .94). OEFpet calculated by use of the 5-minute and 8-minute autoradiographic analyses were equally well correlated with the reference measurements (r = .95 and r = .97, respectively). There were no significant differences between values of MMRO2pet calculated by use of the steady-state, 5-minute, and 8-minute autoradiographic analyses (P = NS by ANOVA). Regional values of MBFpet, OEFpet, and MMRO2pet were homogeneously distributed and similar to the whole-heart values both at baseline and during the various pharmacological interventions.
CONCLUSIONS: Accurate quantification of OEF and MMRO2 is feasible with 15O2 inhalation and PET imaging using both the steady-state and autoradiographic analytical approaches. These studies suggest the applicability of this method for quantitative assessments of regional cardiac oxidative metabolism in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772705     DOI: 10.1161/01.cir.94.4.808

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Use of carbon 11-acetate for the measurement of myocardial oxygen consumption.

Authors:  O Akinboboye; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

2.  Assessing mitochondrial respiration in isolated hearts using (17)O MRS.

Authors:  Ming Lu; Bharath Atthe; Gheorghe D Mateescu; Chris A Flask; Xin Yu
Journal:  NMR Biomed       Date:  2011-12-09       Impact factor: 4.044

3.  Assessment of myocardial oxygenation with MRI.

Authors:  Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2013-04

Review 4.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

5.  Cardiac 17O MRI: toward direct quantification of myocardial oxygen consumption.

Authors:  Kyle S McCommis; Xiang He; Dana R Abendschein; Pradeep M Gupte; Robert J Gropler; Jie Zheng
Journal:  Magn Reson Med       Date:  2010-06       Impact factor: 4.668

6.  Quantification of regional myocardial oxygen metabolism in normal pigs using positron emission tomography with injectable (15)O-O (2).

Authors:  Takashi Temma; Hidehiro Iida; Takuya Hayashi; Noboru Teramoto; Youichiro Ohta; Nobuyuki Kudomi; Hiroshi Watabe; Hideo Saji; Yasuhiro Magata
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-04       Impact factor: 9.236

7.  Feasibility study of myocardial perfusion and oxygenation by noncontrast MRI: comparison with PET study in a canine model.

Authors:  Kyle S McCommis; Haosen Zhang; Pilar Herrero; Robert J Gropler; Jie Zheng
Journal:  Magn Reson Imaging       Date:  2007-06-13       Impact factor: 2.546

Review 8.  Translation of myocardial metabolic imaging concepts into the clinics.

Authors:  Adil Bashir; Robert J Gropler
Journal:  Cardiol Clin       Date:  2009-05       Impact factor: 2.213

Review 9.  Advanced tracers in PET imaging of cardiovascular disease.

Authors:  Yesen Li; Wei Zhang; Hua Wu; Gang Liu
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

Review 10.  Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.